BSEUNJHA FORMULATIONS LTD.· Pharmaceuticals & BiotechnologyHighNegative
Announced Mon, 13 Jul, 2026 · 17:12 IST

BSE seeks clarification on significant price movement

Regulatory & LegalExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+6.7%Reaction day
₹24.35
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-1.0%+7.7% vs market
Pharmaceuticals peers, median of 166sector-0.3%+6.9% vs sector

On the reaction day the stock moved 7.7 pts more than Nifty Microcap 250 and 6.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+6.7-1.0+7.7-0.3+6.9
Next day
+9.2-0.4+9.6-0.3+9.5
2d
+10.8-0.8+11.6-0.3+11.1
3d
+10.4-1.9+12.3-1.3+11.8
4d
+6.8-1.3+8.1-0.8+7.6
5d
+2.7-1.0+3.6-0.7+3.4
1w
-2.1-2.8+0.7-2.9+0.8
15d
+7.6+0.4+7.2-2.1+9.7
1m
+13.1+2.4+10.7-0.9+14.1
2m
+36.8+1.0+35.8-1.1+37.9
3m
+30.6+1.8+28.8-2.7+33.3
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 166Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

BSE has asked Unjha Formulations Ltd for clarification following an unusual rise or fall in the share price on July 13, 2026. The exchange wants to make sure investors have the latest relevant information. No penalty, charge, or regulatory action has been announced so far. The company is expected to respond with any undisclosed price-sensitive information.

Likely market impact

Routine exchange query; may cause short-term volatility until company clarifies. No direct regulatory action yet.